Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2008

Bucci M, Roviezzo F, Brancaleone V, Di Lorenzo A, Evangelista S, Gori M, et al. ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice. Vascul Pharmacol. 2008;49(2-3):84-90.

Collins P, Budde U, Rand JH, Federici AB, Kessler CM. Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome. Haemophilia. 2008;14 Suppl 3:49-55.

Kerr SM, Liechty B, Patel R, Harrop JS. Percutaneous vertebral compression fracture management with polyethylene mesh-contained morcelized allograft bone. Curr Rev Musculoskelet Med. 2008;1(2):84-7.

Building a prostate. Nat Med. 2008;14(12):1317.

Emanuel P, Qin L, Harpaz N. Calcifying fibrous tumor of small intestine. Ann Diagn Pathol. 2008;12(2):138-41.

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118(6):2111-20.

Di Bartolo DL, Cannon M, Liu Y-, Renne R, Chadburn A, Boshoff C, et al. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 2008;111(9):4731-40.

Milette F. De novo intraepidermal epithelioid melanocytic dysplasia? J Cutan Pathol. 2008;35(12):1148-9; author reply 1150.

Martinez-Salamanca JI, Ramanathan R, Rao S, Mandhani A, Leung R, Horninger W, et al. Second Prize: Pelvic neuroanatomy and innovative approaches to minimize nerve damage and maximize cancer control in patients undergoing robot-assisted radical prostatectomy. J Endourol. 2008;22(6):1137-46.

Menu E, Garcia J, Huang X, Di Liberto M, Toogood PL, Chen I, et al. A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model. Cancer Res. 2008;68(14):5519-23.